CSPIX
Price
$15.26
Change
-$0.04 (-0.26%)
Updated
Oct 6 closing price
Net Assets
20.96M
RSLDX
Price
$76.73
Change
-$0.00 (-0.00%)
Updated
Oct 6 closing price
Net Assets
82.15B
Interact to see
Advertisement

CSPIX vs RSLDX

Header iconCSPIX vs RSLDX Comparison
Open Charts CSPIX vs RSLDXBanner chart's image
Calvert Global Small-Cap Equity I
Price$15.26
Change-$0.04 (-0.26%)
VolumeN/A
Net Assets20.96M
American Funds SMALLCAP World R5E
Price$76.73
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets82.15B
CSPIX vs RSLDX Comparison Chart in %
View a ticker or compare two or three
VS
CSPIX vs. RSLDX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPIX is a Buy and RSLDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLDX has more cash in the bank: 82.2B vs. CSPIX (21M). CSPIX pays higher dividends than RSLDX: CSPIX (1.17) vs RSLDX (0.78). CSPIX was incepted earlier than RSLDX: CSPIX (16 years) vs RSLDX (10 years). CSPIX (1.82) is less costly to investors than RSLDX (0.80). CSPIX is a more actively managed with annual turnover of: 46.00 vs. RSLDX (32.00). RSLDX has a lower initial minimum investment than CSPIX: RSLDX (250) vs CSPIX (1000000). RSLDX annual gain was more profitable for investors over the last year : 9.24 vs. CSPIX (-2.30). RSLDX return over 5 years is better than : 12.90 vs. CSPIX (4.34).
CSPIXRSLDXCSPIX / RSLDX
Total Expense Ratio1.060.80133%
Annual Report Gross Expense Ratio1.820.80228%
Fund Existence16 years10 years-
Gain YTD4.15212.72633%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets21M82.2B0%
Annual Yield % from dividends1.170.78150%
Returns for 1 year-2.309.24-25%
Returns for 3 years26.6945.3359%
Returns for 5 years4.3412.9034%
Returns for 10 years-4.00N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCAB0.820.13
+18.19%
BioAtla
PNFP93.600.24
+0.26%
Pinnacle Financial Partners
JPM309.180.65
+0.21%
JPMorgan Chase & Co
BCRX7.02-0.13
-1.82%
BioCryst Pharmaceuticals
OPRX17.68-1.07
-5.71%
OptimizeRx Corp